If you'd like to claim this company profile for Clover Biopharmaceuticals, please Contact Us
Clover Biopharmaceuticals: Partnerships and Licensing
Partnership and licensing opportunities from Clover Biopharmaceuticals.
Partnership Title: Partnership Opportunity
Partnership Description ...
The COVID-19 pandemic presents unprecedented challenges to communities around the world. Members of the scientific and public health communities need to collaborate with each other now more than ever to tackle this disease. In response to the global COVID-19 pandemic, Clover entered into partnerships with the Coalition for Epidemic Preparedness Innovations (CEPI), GSK, and Dynavax for the advancement of its COVID-19 vaccine program. We aim to work with our partners to deliver safe and effective vaccines to all countries and regions affected by the pandemic.
Partnership Types ...
- Licencing In
We are looking for products from
other companies to 'in-license'.
- Licencing Out
We offer our products to other
companies on an 'out-licensing' basis.
- Research and Development
We offer co-development
Partnership Category Areas ...
- BioPharmaceuticals-Proprietary Formulations
- Proprietary Formulations
- Proprietary Formulations-Clinical Development
Partnership Formulation Areas ...
Partnership Therapy Areas ...
- Anti-infectives for systemic use
- Antineoplastic and Immunomodulating Agents
- -Antineoplastic and Immunomodulating Products-General Group
Claim This Profile
This is the Partnership and Licensing section of the company profile page for
Clover Biopharmaceuticals on the
Directory. Companies listed on the directory can update their business information free of charge. If
this is your company and you'd like to claim this profile, please
Clover Biopharmaceuticals company details, activities,
contacts and reviews.
Clover Biopharmaceuticals partnership and licensing
Clover Biopharmaceuticals latest news, announcements and
Clover Biopharmaceuticals documents, images and videos.
Clover Biopharmaceuticals global factories, offices and
Clover Biopharmaceuticals legal and financial information.